PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 184 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $806,155 | -44.7% | 35,973 | +0.4% | 0.10% | -46.4% |
| Q2 2023 | $1,457,125 | +200.0% | 35,828 | +257.3% | 0.18% | +232.7% |
| Q1 2023 | $485,756 | -62.0% | 10,028 | -70.0% | 0.06% | -62.1% |
| Q4 2022 | $1,277,168 | -27.6% | 33,460 | -4.8% | 0.14% | -24.5% |
| Q3 2022 | $1,765,000 | +111.9% | 35,157 | +57.4% | 0.19% | +115.7% |
| Q1 2022 | $833,000 | +170.5% | 22,330 | +189.1% | 0.09% | +169.7% |
| Q4 2021 | $308,000 | -68.0% | 7,723 | -70.2% | 0.03% | -55.4% |
| Q3 2021 | $964,000 | +150.4% | 25,920 | +184.5% | 0.07% | +117.6% |
| Q2 2021 | $385,000 | -85.2% | 9,111 | -83.4% | 0.03% | -85.0% |
| Q1 2021 | $2,602,000 | +97.1% | 54,950 | +154.0% | 0.23% | +130.6% |
| Q4 2020 | $1,320,000 | +34.0% | 21,634 | +2.7% | 0.10% | +55.6% |
| Q3 2020 | $985,000 | – | 21,060 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
| Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
| ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
| COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
| GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
| SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
| Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
| Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |